Cargando…

Clinical and pathohistological characteristics of Alport spectrum disorder caused by COL4A4 mutation c.193-2A>C: a case series

AIM: To present the pathohistological and clinical characteristics of five Croatian families with Alport spectrum disorders caused by splice acceptor pathogenic variant c.193-2A>C in COL4A4 at the genomic position chr2:227985866. METHODS: The study enrolled five probands with kidney biopsy analys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Šenjug, Petar, Nikuševa, Tamara, Martić, Šenjug Perica, Marija, Oroz, Maja, Horaček, Matija, Gotovac, Kristina, Jerčić, Galešić, Krešimir, Galešić, Danica, Ljubanović
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Medical Schools 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275942/ https://www.ncbi.nlm.nih.gov/pubmed/34212557 http://dx.doi.org/10.3325/cmj.2021.62.204

Ejemplares similares

Autosomal recessive Alport syndrome caused by a novel COL4A4 splice site mutation: a case report
por: Šenjug, Petar, et al.
Publicado: (2019)

Clinical and histopathological characteristics of COL4A3 c.2881+1G>A variant causing Alport spectrum disorders in Croatian population
por: Horaček, Matija, et al.
Publicado: (2023)

Immune-mediated diseases after coronavirus disease 2019 vaccination: rare but important complication
por: Zagorec, Nikola, et al.
Publicado: (2022)

Resistant and Relapsing Collapsing Glomerulopathy Successfully Treated with Rituximab—A Case Report
por: Zagorec, Nikola, et al.
Publicado: (2022)

Letter to the Editor: Characterization of Choriocapillaris and Choroidal Abnormalities in Alport Syndrome
por: Bosnar, Damir, et al.
Publicado: (2023)

De novo immune complex–mediated membranoproliferative glomerulonephritis after COVID-19 vaccination
por: Zagorec, Nikola, et al.
Publicado: (2023)

Crescentic Glomerulonephritis Due to Enterococcal Endocarditis
por: Klarić, Dragan, et al.
Publicado: (2023)

IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis
por: Pačić, Arijana, et al.
Publicado: (2017)

PULMONARY HEMORRHAGE AND CRESCENTIC GLOMERULONEPHRITIS IN A PATIENT WITH SEROPOSITIVE ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE AND ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES
por: Sreter, Katherina Bernadette, et al.
Publicado: (2022)

A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndrome
por: Odiatis, Christoforos, et al.
Publicado: (2020)

The Onset of Systemic Oxidative Stress Associated with the Accumulation of Lipid Peroxidation Product Acrolein in the Skin of Patients with Small-Vessel Vasculitis
por: Sredoja Tisma, Vesna, et al.
Publicado: (2021)

A CHILD WITH DENSE DEPOSIT DISEASE AND DECREASED CLASSIC COMPLEMENT PATHWAY ACTIVITY
por: Trutin, Ivana, et al.
Publicado: (2021)

Magnetic and Electrical Behaviors of the Homo- and Heterometallic 1D and 3D Coordination Polymers Based on the Partial Decomposition of the [Cr(C(2)O(4))(3)](3−) Building Block
por: Kanižaj, Lidija, et al.
Publicado: (2020)

Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome
por: Liu, Jian-Hong, et al.
Publicado: (2017)

The 2019 and 2021 International Workshops on Alport Syndrome
por: Daga, Sergio, et al.
Publicado: (2022)

Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria
por: Savige, Judy, et al.
Publicado: (2021)

COL4A6 is dispensable for autosomal recessive Alport syndrome
por: Murata, Tomohiro, et al.
Publicado: (2016)

Identification of 27 Novel Variants in Genes COL4A3, COL4A4, and COL4A5 in Lithuanian Families With Alport Syndrome
por: Cerkauskaite, Agne, et al.
Publicado: (2022)

Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X‐linked Alport syndrome
por: Zhang, Yanqin, et al.
Publicado: (2019)

Genotype–phenotype correlations for COL4A3–COL4A5 variants resulting in Gly substitutions in Alport syndrome
por: Gibson, Joel T., et al.
Publicado: (2022)

Novel mutations of COL4A3, COL4A4, and COL4A5 genes in Chinese patients with Alport Syndrome using next generation sequence technique
por: Zhao, Xuechao, et al.
Publicado: (2019)

Trimerization and Genotype–Phenotype Correlation of COL4A5 Mutants in Alport Syndrome
por: Kamura, Misato, et al.
Publicado: (2020)

Novel heterozygous mutation in COL4A4 responsible for Alport syndrome in a Chinese family
por: Du, Ran, et al.
Publicado: (2022)

New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells
por: Daga, Sergio, et al.
Publicado: (2019)

Clinical Manifestations of Alport Syndrome-Diffuse Leiomyomatosis Patients With Contiguous Gene Deletions in COL4A6 and COL4A5
por: Zhou, Xi, et al.
Publicado: (2021)

Should We Diagnose Autosomal Dominant Alport Syndrome When There Is a Pathogenic Heterozygous COL4A3 or COL4A4 Variant?
por: Savige, Judy
Publicado: (2018)

Correlation of Cervical Smear and Pathohistological Findings
por: Asotic, Amir, et al.
Publicado: (2014)

Creation of X-linked Alport syndrome rat model with Col4a5 deficiency
por: Namba, Masumi, et al.
Publicado: (2021)

The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome
por: Yamamura, Tomohiko, et al.
Publicado: (2022)

Effect of mycophenolate mofetil on progression of interstitial fibrosis and tubular atrophy after kidney transplantation: a retrospective study
por: Mihovilović, Karlo, et al.
Publicado: (2014)

Expression Pattern of α-Tubulin, Inversin and Its Target Dishevelled-1 and Morphology of Primary Cilia in Normal Human Kidney Development and Diseases
por: Solic, Ivana, et al.
Publicado: (2021)

Alport syndrome caused by a COL4A5 deletion and exonization of an adjacent AluY
por: Nozu, Kandai, et al.
Publicado: (2014)

Pathohistological features of the aging human lacrimal gland
por: Hat, Koraljka, et al.
Publicado: (2023)

Primary Sjögren’s syndrome presenting as hypokalemic paralysis
por: Morović-Vergles, Jadranka, et al.
Publicado: (2007)

Genotype-Phenotype Correlations for Pathogenic COL4A3–COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome
por: Savige, Judy, et al.
Publicado: (2022)

Molecular dynamics and minigene assay of new splicing variant c.4298-20T>A of COL4A5 gene that cause Alport syndrome
por: Liang, Lei, et al.
Publicado: (2023)

Alport Syndrome: De Novo Mutation in the COL4A5 Gene Converting Glycine 1205 to Valine
por: Antón-Martín, Pilar, et al.
Publicado: (2012)

Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5
por: Yamamura, Tomohiko, et al.
Publicado: (2020)

The First COL4A5 Exon 41A Glycine Substitution in a Family With Alport Syndrome
por: Wang, Fang, et al.
Publicado: (2020)

Publisher Correction: Creation of X-linked Alport syndrome rat model with Col4a5 deficiency
por: Namba, Masumi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l5iog58qrkr3sqv4hnk0093tb6